Bap Pharma Ltd
Bap Pharma Ltd, a prominent player in the pharmaceutical industry, is headquartered in Great Britain and operates extensively across Europe and beyond. Founded in 2005, the company has established itself as a leader in the development and distribution of high-quality generic and specialty pharmaceuticals. Bap Pharma's core offerings include a diverse range of medications that cater to various therapeutic areas, including oncology, cardiology, and infectious diseases. What sets Bap Pharma apart is its commitment to innovation and quality, ensuring that all products meet stringent regulatory standards. With a strong market position, Bap Pharma has achieved significant milestones, including numerous successful product launches and partnerships that enhance its global reach. The company continues to focus on improving patient outcomes through its unique and effective pharmaceutical solutions.
DitchCarbon Score
How does Bap Pharma Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Bap Pharma Ltd's score of 18 is lower than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Bap Pharma Ltd's reported carbon emissions
Bap Pharma Ltd, headquartered in Great Britain, has not publicly disclosed specific carbon emissions data for the most recent year. However, the company is committed to achieving net-zero emissions, demonstrating its dedication to sustainability within the pharmaceuticals, biotechnology, and life sciences sector. Bap Pharma has made a near-term commitment to reduce its carbon footprint, although specific reduction targets have not been detailed. The company is actively working towards its climate goals, aligning with industry standards and best practices. As part of its climate strategy, Bap Pharma is focused on addressing its emissions across all scopes, including Scope 1, 2, and 3, although specific figures are currently unavailable. Overall, Bap Pharma's commitment to net-zero emissions reflects a proactive approach to climate action, positioning the company as a responsible player in the industry.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Bap Pharma Ltd is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
